APOE and APOC1 genetic polymorphisms in age-associated memory impairment

Neurogenetics

Volumn 3, Issue 4, 2001, Pages 215-219

  Bartres Faz D ^a   Clemente, L C ^a   Junque C ^a   Valveny, N ^a   Lopez Alomar A ^a   Sanchez Aldeguer J ^b   Lopez Guillen A ^c   Moral, P ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c INSTITUT CATALÀ DE LA SALUT   (Spain)

Author keywords

Aging; Apolipoproteins; Genetic; Impairment; Memory

Indexed keywords

APOLIPOPROTEIN C; APOLIPOPROTEIN E;

ADULT; AGED; AGING; ARTICLE; COGNITION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; MALE; MEMORY DISORDER;

AGED; AGING; APOLIPOPROTEINS C; APOLIPOPROTEINS E; COGNITION; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MALE; MEMORY DISORDERS; MIDDLE AGE; POLYMORPHISM (GENETICS); SUPPORT, NON-U.S. GOV'T;

EID: 0035491286     PISSN: 13646745     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100480100122     Document Type: Article

References (35)

1. Crook TH, Bartus RT, Ferris SH, Whitehouse P, Cohen GD, Gershon S (1986) Age-associated memory impairment: proposed diagnostic criteria and measures of clinical change. Report of a National Institute of Mental Health work group. Dev Neuropsychol 2:261-276
2. Soininen HS, Partanen K, Pitkanen A, Vainio P, Hänninen T, Hallikainen M, Koivisto K, Riekkinen PJ (1994) Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age-associated memory impairment. Neurology 44:1660-1668
3. Koivisto K, Reinikainen KJ, Hänninen T, Vanhanen M, Helkala E-L, Mykkänen L, Laakso M, Pyörälä K, Riekkinen PJ (1995) Prevalence of age-associated memory impairment in a randomly selected population from eastern Finland. Neurology 45:741-746
4. 99mTc-HMPAO-SPECT in normal aging, age-associated-memory impairment, and probable Alzheimer's disease. J Am Geriatr Soc 44:133-138
5. Hänninen T, Hallikainen M, Koivisto K, Helkala E-L, Reinikainen KJ, Soininen H, Mykkänen L, Laakso M, Pyörälä K, Riekkinen PJ (1995) A follow-up study of age-associated memory impairment: neuropsychological predictors of dementia. J Am Geriatr Soc 43:1007-1015
6. Helkala E-L, Koivisto K, Hänninen T, Vanhanen M, Kuusisto J, Mykkanen L, Laakso M, Riekkinen P (1997) Stability of age-associated memory impairment during a longitudinal population-based study. J Am Geriatr Soc 45:120-122
7. Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, Hulette C, Crain B, Goldbager D, Roses AD (1993) Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43:1467-1472
8. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 90:1977-1981
9. Corder EH, Saunders AM, Strittmatter WJ, Schmechel D, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261:921-923
10. Rubinsztein D, Easton D (1999) Apolipoprotein E genetic variation and Alzhiemer's disease. Dement Geriatr Cogn Disord 10:199-209
11. Förstl H, Hentschel F, Sattel H, Geiger-Kabisch C, Besthorn C, Czech C, Mönning U, Beyreuther K (1995) Age-associated memory impairment and early Alzheimer's disease. Only time will tell the difference. Arzneimittelforschung/Drug Res 45: 394-397
12. Palumbo B, Cadini D, Nocentini G, Filipponi E, Fravolini ML, Senin U (1999) Angiotensin converting enzyme deletion allele in different kinds of dementia disorders. Neurosci Lett 267:97-100
13. Bartrés-Faz D, Junqué C, López A, Valveny N, Moral P, Gálvez E, López T, Moya A, Navarro JL, Clemente IC (1999) Apo E influences declarative and procedural learning in age-associated memory impairment. Neuroreport 10:2923-2927
14. Templeton AR (1995) A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping or DNA sequencing. V. Analysis of case/control sampling designs: Alzheimer's disease and the apolipoprotein E locus. Genetics 140:403-409
15. Scacchi R, Gambina G, Ruggeri M, Martini MC, Ferrari G, Silvestri M, Schiavon R, Corbo RM (1999) Plasma levels of apolipoprotein E and genetic markers in elderly patients with Alzheimer's disease. Neurosci Lett 259:33-36
16. Kamino K, Yoshiiwa A, Nishiwaki Y, Nagano K, Yamamoto H, Kobayashi T, Nonomura Y, Yoneda H, Sakai T, Imagawa M, Miki T, Ogihara T (1996) Genetic association study between senile dementia of Alzhimer's type and APOE/C1/C2 gene cluster. Gerontology 42 [Suppl]:12-19
17. Poduslo SE, Neal M, Scwankhaus J (1995) A closely linked gene to apolipoprotein E may serve as an additional risk factor for Alzheimer's disease. Neurosci Lett 201:81-83
18. Poduslo SE, Neal M, Herring K, Shelly J (1998) The apolipoprotein CI A allele as a risk factor for Alzheimer's disease. Neurochem Res 23:361-367
19. Drigalenko E, Poduslo S, Elston R (1998) Interaction of the apolipoprotein E and CI loci in predisposing to late-onset Alzheimer's disease. Neurology 51:131-135
20. Nillesen WM, Smeets HJM, Van Oost BA (1990) Human Apo CI HpaI restriction site polymorphism revealed by the polymerase chain reaction. Nucleic Acids Res 18:3428
21. Wenham PR, Price WH, Blandell G (1991) Apolipoprotein E genotyping by one-stage PCR. Lancet 337:1158-1159
22. Schneider S, Kueffer JM, Excoffier L (1996) Arlequin (ver 1.0) A software environment for the analysis of population genetic data. Genetics and Biometry Laboratory, University of Geneva, Switzerland
23. Weir BS (1990) Genetic data analysis. Sinauer, Sunderland, Mass
24. McCarron MO, Delong D, Alberts MJ (1999) APOE genotype as a risk factor for ischemic cerebrovascular disease. A metaanalysis. Neurology 53:1308-1311
25. Sorbi S, Nacmias B, Forleo P, Latorraca S, Gobbini I, Bracco L, Piacentini S, Amacducci L (1994) ApoE allele frequencies in Italian sporadic and familial Alzheimer's disease. Neurosci Lett 177:100-102
26. Schmidt R, Schmidt H, Fazekas F, Schumacher M, Niederkorn K, Kapeller P, Weinrauch V, Kostner GM (1997) Apolipoprotein E polymorphism and silent micro angiopathy-related cerebral damage. Results of the Austrian stroke prevention study. Stroke 28:951-956
27. Junqué C, Pujol J, Vendrell P, Bruna O, Jódar M, Ribas JC, Viñas J, Capdevila A, Martí-Vilalta JL (1990) Leuko-araiosis on magnetic resonance imaging and speed of mental processing. Arch Neurol 47:151-156
28. DeCarli C, Murphy DGM, Tranh M, Grady CL, Haxby JV, Gillette JA, Salerno JA, Gonzales-Aviles A, Horwitz B, Rapoport SI, Schapiro MB (1995) The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults. Neurology 45:2077-2084
29. Swan GE, DeCarli C, Miller BL, Reed T, Wolf PA, Jack LM, Carmelli D (1998) Association of middle blood pressure to late-life cognitive decline and brain morphology. Neurology 51:986-993
30. Hänninen T, Hallikainen M, Koivisto K, Partanen K, Laakso MP, Riekkinen PJ, Soininen H (1997) Decline of frontal lobe functions in subjects with age-associated memory impairment. Neurology 48:148-153
31. Bartrés-Faz D, Junqué C, Clemente IC, Serra-Grabulosa JM, Guardia J, López-Alomar A, Sánchez-Aldeguer J, Mercader JM, Bargalló N, Olondo, Moral P (2001) MRI and genetic correlates of cognitive function in elders with memory impairment. Neurobiol Aging 22:449-459
32. De Kniff P, van Duijn CM (1998) Role of APOE in dementia: a critical reappraisal. Haemostasis 28:195-201
33. Lehtovirta ML, Laakso MP, Frisoni GB, Soininen H (2000) How does the apolipoprotein E genotype modulate the brain in aging and in Alzheimer's disease? A review of neuroimaging studies. Neurobiol Aging 21:293-300
34. Jong MC, Van Dijk KW, Dahlmans VEH, Van Der Boom H, Kobayashi K, Oka K, Siest G, Chan L, Hofker MH, Havekes LM (1999) Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor. Biochem J 338:281-287
35. Xu Y, Berglund L, Ramakrishnan R, Mayeux R, Ngai C, Holleran S, Tycko B, Tycko B, Leff T, Shacher NS (1999) A common Hpa I RFLP of apolipoprotein C-I increases gene transcription and exhibits an ethnically distinct pattern of linkage disequilibrium with the alleles of apolipoprotein E. J Lipid Res 40:50-58